Fig. 2.
OS rate of uterine carcinosarcoma patients based on the presence of pathological necrosis (A) and more than 10% of the tumor being unenhanced on MRI (B). OS rate (C) and PFS rate (D) according to FIGO stage.
FIGO, International Federation of Gynecology and Obstetrics; MRI, magnetic resonance imaging; OS, overall survival; PFS, progression-free survival.
